Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative.
Andrea N EdgintonJoseph C LarsonFrits Richard RosendaalSusan R HeckbertJ David CurbLawrence S PhillipsAlison E BairdCharles B EatonRandall S StaffordPublished in: Research and practice in thrombosis and haemostasis (2018)
Abnormal levels of biomarkers of thrombosis risk identified women at increased risk of future venous thrombosis with oral menopausal hormone therapy. Findings support the potential for clinical use of D-dimer testing in advance of hormone therapy prescription.